With tests already done on animals, the company owned by billionaire Elon Musk, Neuralink, is preparing to implement brain chips in humans. The company, which was founded in 2016, has announced a vacancy for a Director of Clinical Trials. Information from the state of São Paulo.
In the announcement, Neuralink explains that the new employee will “work closely with some of the most innovative clinicians and engineers, as well as work with the first participants in Neuralink’s clinical trials.”
According to Musk, the expectation is that the chips can be used in medicine, including tetraplegics easy going on.
“We have a chance to restore the full functionality of a person who has sustained a spinal injury. Neuralink works well with monkeys and we are doing a lot of testing and confirming that it is very safe and reliable. The Neuralink device can, as he said at the Wall Street Journal event.”
The symbiosis of machine and human
The technology used by the company will create a symbiosis between The machine and the human mindThis allows the treatment of blindness paralysis or even control of the brain over the organs.
For this purpose, flexible lines of electrodes are placed near the neurons, which are placed with fine needles.
“Entrepreneur. Music enthusiast. Lifelong communicator. General coffee aficionado. Internet scholar.”
More Stories
Viva Airlines opens the way from Sao Paulo to Medellin – 06/25/2022 – Market
How many Netflix subscribers in Brazil?
Inter launches a clothing brand